Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueNo recent work listed

Olivier Soriani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9485-3992; OpenAlex author ID A5034019031. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer. Last author DOI 10.1136/gutjnl-2021-326610↗
  2. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition. Co-author DOI 10.3390/cancers14153737↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Richard Tomasini · 2 shared papers, 2022–2023 · strength 0.30
  2. Stefania Cannone · 1 shared paper, 2022 · strength 0.15
  3. Maria Raffaella Greco · 1 shared paper, 2022 · strength 0.15
  4. Tiago M. A. Carvalho · 1 shared paper, 2022 · strength 0.15
  5. Stephan J. Reshkin · 1 shared paper, 2022 · strength 0.15
  6. Katrine Zeeberg · 1 shared paper, 2022 · strength 0.15
  7. Rosa Angela Cardone · 1 shared paper, 2022 · strength 0.15
  8. François Bertucci · 1 shared paper, 2023 · strength 0.14
  9. Corinne Bousquet · 1 shared paper, 2023 · strength 0.14
  10. Raphaël Rapetti‐Mauss · 1 shared paper, 2023 · strength 0.14
  11. Zainab Hussain · 1 shared paper, 2023 · strength 0.14
  12. Georgios Efthymiou · 1 shared paper, 2023 · strength 0.14
  13. Jérémy Nigri · 1 shared paper, 2023 · strength 0.14
  14. Nelson Dusetti · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.